Skip to contentT
TuHURA Biosciences, Inc.
T
HURATuHURA Biosciences, Inc. Q3 2024 · 10-Q
Revenue$0.00$0.00derivedno prior Q3 2023 on file Net Income-$5.58M-$5.58Mno prior Q3 2023 on file EPS Diluted-$0.54-$0.54no prior Q3 2023 on file Operating Cash Flow-$1,889,000—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
TuHURA Biosciences, Inc. · CIK 1498382 · Engraved from SEC EDGAR
Free Cash Flowderived-$3,228,468— ended Sep 30, 2024 · filed Nov 14, 2024 · 45 d after period end